Literature DB >> 27677179

tPA Modulation of the Blood-Brain Barrier: A Unifying Explanation for the Pleiotropic Effects of tPA in the CNS.

Linda Fredriksson1, Daniel A Lawrence2, Robert L Medcalf3.   

Abstract

The plasminogen activation (PA) system is best known for its role in fibrinolysis. However, it has also been shown to regulate many nonfibrinolytic functions in the central nervous system (CNS). In particular, tissue-type plasminogen activator (tPA) is reported to have pleiotropic activities in the CNS, regulating events such as neuronal plasticity, excitotoxicity, and cerebrovascular barrier integrity, whereas urokinase-type plasminogen activator is mainly associated with tissue remodeling and cell migration. It has been suggested that the role tPA plays in controlling barrier integrity may provide a unifying mechanism for the reported diverse, and often opposing, functions ascribed to tPA in the CNS. Here we will review the possibility that the pleiotropic effects reported for tPA in physiologic and pathologic processes in the CNS may be a consequence of its role in the neurovascular unit in regulation of cerebrovascular responses and subsequently parenchymal homeostasis. We propose that this might offer an explanation for the ongoing debate regarding the neurotoxic versus neuroprotective roles of tPA. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27677179      PMCID: PMC5848490          DOI: 10.1055/s-0036-1586229

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  157 in total

1.  Compartment- and context-specific changes in tissue-type plasminogen activator (tPA) activity following brain injury and pharmacological stimulation.

Authors:  Maithili Sashindranath; Andre Laval Samson; Catherine Eliza Downes; Peter John Crack; Andrew John Lawrence; Qiao-Xin Li; Ashley Quan Ping Ng; Nigel Charles Jones; Jessica Jade Farrugia; Eman Abdella; Jean-Dominique Vassalli; Rime Madani; Robert Lindsay Medcalf
Journal:  Lab Invest       Date:  2011-04-25       Impact factor: 5.662

Review 2.  An astrocyte bridge from synapse to blood flow.

Authors:  Rheinallt Parri; Vincenzo Crunelli
Journal:  Nat Neurosci       Date:  2003-01       Impact factor: 24.884

3.  An astrocytic basis of epilepsy.

Authors:  Guo-Feng Tian; Hooman Azmi; Takahiro Takano; Qiwu Xu; Weiguo Peng; Jane Lin; NancyAnn Oberheim; Nanhong Lou; Xiaohai Wang; H Ronald Zielke; Jian Kang; Maiken Nedergaard
Journal:  Nat Med       Date:  2005-08-14       Impact factor: 53.440

4.  t-PA-specific modulation of a human blood-brain barrier model involves plasmin-mediated activation of the Rho kinase pathway in astrocytes.

Authors:  Be'eri Niego; Roxann Freeman; Till B Puschmann; Ann M Turnley; Robert L Medcalf
Journal:  Blood       Date:  2012-01-19       Impact factor: 22.113

Review 5.  Clinical implications of the involvement of tPA in neuronal cell death.

Authors:  S E Tsirka
Journal:  J Mol Med (Berl)       Date:  1997-05       Impact factor: 4.599

6.  Specific lysis of an iliofemoral thrombus by administration of extrinsic (tissue-type) plasminogen activator.

Authors:  W Weimar; J Stibbe; A J van Seyen; A Billiau; P De Somer; D Collen
Journal:  Lancet       Date:  1981-11-07       Impact factor: 79.321

7.  Neuroserpin, an axonally secreted serine protease inhibitor.

Authors:  T Osterwalder; J Contartese; E T Stoeckli; T B Kuhn; P Sonderegger
Journal:  EMBO J       Date:  1996-06-17       Impact factor: 11.598

8.  Traumatic brain injury-induced excitotoxicity assessed in a controlled cortical impact model.

Authors:  A M Palmer; D W Marion; M L Botscheller; P E Swedlow; S D Styren; S T DeKosky
Journal:  J Neurochem       Date:  1993-12       Impact factor: 5.372

9.  Tissue plasminogen activator is a potent activator of PDGF-CC.

Authors:  Linda Fredriksson; Hong Li; Christina Fieber; Xuri Li; Ulf Eriksson
Journal:  EMBO J       Date:  2004-09-16       Impact factor: 11.598

10.  Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials.

Authors:  Werner Hacke; Geoffrey Donnan; Cesare Fieschi; Markku Kaste; Rüdiger von Kummer; Joseph P Broderick; Thomas Brott; Michael Frankel; James C Grotta; E Clarke Haley; Thomas Kwiatkowski; Steven R Levine; Chris Lewandowski; Mei Lu; Patrick Lyden; John R Marler; Suresh Patel; Barbara C Tilley; Gregory Albers; Erich Bluhmki; Manfred Wilhelm; Scott Hamilton
Journal:  Lancet       Date:  2004-03-06       Impact factor: 79.321

View more
  17 in total

1.  Tissue plasminogen activator-based nanothrombolysis for ischemic stroke.

Authors:  Shan Liu; Xiaozhou Feng; Rong Jin; Guohong Li
Journal:  Expert Opin Drug Deliv       Date:  2017-09-28       Impact factor: 6.648

2.  Critical Role of Monocyte Recruitment in Optic Nerve Damage Induced by Experimental Optic Neuritis.

Authors:  Marcos L Aranda; Diego Guerrieri; Gonzalo Piñero; María F González Fleitas; Florencia Altschuler; Hernán H Dieguez; María I Keller Sarmiento; Mónica S Chianelli; Pablo H Sande; Damián Dorfman; Ruth E Rosenstein
Journal:  Mol Neurobiol       Date:  2019-05-01       Impact factor: 5.590

3.  The Role of Fibrinolytic System in Health and Disease.

Authors:  Hau C Kwaan
Journal:  Int J Mol Sci       Date:  2022-05-09       Impact factor: 6.208

4.  Compartmentalized Actions of the Plasminogen Activator Inhibitors, PAI-1 and Nsp, in Ischemic Stroke.

Authors:  Daniel Torrente; Enming Joseph Su; Linda Fredriksson; Mark Warnock; David Bushart; Kris M Mann; Cory D Emal; Daniel A Lawrence
Journal:  Transl Stroke Res       Date:  2022-02-04       Impact factor: 6.800

Review 5.  Therapeutic Potential of Cytokines in Demyelinating Lesions After Stroke.

Authors:  Yi-Sha Guo; Mei Yuan; Yu Han; Xin-Ya Shen; Zhen-Kun Gao; Xia Bi
Journal:  J Mol Neurosci       Date:  2021-05-10       Impact factor: 3.444

Review 6.  Serine Proteases and Chemokines in Neurotrauma: New Targets for Immune Modulating Therapeutics in Spinal Cord Injury.

Authors:  Roxana N Beladi; Kyle S Varkoly; Lauren Schutz; Liqiang Zhang; Jordan R Yaron; Qiuyun Guo; Michelle Burgin; Ian Hogue; Wesley Tierney; Wojciech Dobrowski; Alexandra R Lucas
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.708

7.  Pinocembrin Protects Blood-Brain Barrier Function and Expands the Therapeutic Time Window for Tissue-Type Plasminogen Activator Treatment in a Rat Thromboembolic Stroke Model.

Authors:  YinZhong Ma; Li Li; LingLei Kong; ZhiMei Zhu; Wen Zhang; JunKe Song; Junlei Chang; GuanHua Du
Journal:  Biomed Res Int       Date:  2018-04-22       Impact factor: 3.411

8.  Tissue Plasminogen Activator Promotes TXNIP-NLRP3 Inflammasome Activation after Hyperglycemic Stroke in Mice.

Authors:  Saifudeen Ismael; Sanaz Nasoohi; Arum Yoo; Heba A Ahmed; Tauheed Ishrat
Journal:  Mol Neurobiol       Date:  2020-03-14       Impact factor: 5.682

9.  Editorial: The Role of the Plasminogen Activating System in Neurobiology.

Authors:  Robert L Medcalf; Daniel A Lawrence
Journal:  Front Cell Neurosci       Date:  2016-10-04       Impact factor: 5.505

10.  Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke.

Authors:  Enming Joseph Su; Chunzhang Cao; Linda Fredriksson; Ingrid Nilsson; Christina Stefanitsch; Tamara K Stevenson; Juanjuan Zhao; Margret Ragsdale; Yu-Yo Sun; Manuel Yepes; Chia-Yi Kuan; Ulf Eriksson; Dudley K Strickland; Daniel A Lawrence; Li Zhang
Journal:  Acta Neuropathol       Date:  2017-07-19       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.